myriad genetics stock analysis

MYGN Myriad Genetics - Stock quote performance technical chart analysis SmartSelect Ratings Group Leaders and the latest company headlines. Learn more about our purpose.

Myriad Genetics Nasdaq Mygn Solid Profits Have Weak Fundamentals Simply Wall St News

MYGN stock analysis from Seeking Alphas top analysts.

. With 77476578 shares available for purchase and an average trading volume over the past 10 trading days of 475619 it would take at least 8964 days for all of the short holders to cover their shorts. Analysis of Myriad Genetics Naive Prediction A naive forecasting model for Myriad Genetics is a special case of the moving average forecasting where the number of pe. And make sure their analysis is clear and in no way misleading or deceptive.

Technical Analysis Summary for Myriad Genetics Inc with Moving Average Stochastics MACD RSI Average Volume. Myriad is a genetic testing and precision medicine company. Their forecasts range from 2500 to 3500.

The company offers myRisk Hereditary Cancer a DNA sequencing test for hereditary cancers. Myriad Genetics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stocks chart. A rank of 37 means that 63 of stocks appear more favorable to our system.

3 equities research analysts have issued 1-year target prices for Myriad Genetics stock. That tiny 240 million company now has a market cap of 45 billion compared to myriad genetics with a 25 billion market cap. Myriad Genetics Inc.

InvestorsObserver gives Myriad Genetics Inc MYGN an overall rank of 37 which is below average. Myriad is engaged in the discovery development and marketing of transformative molecular diagnostic tests. MYGN on MSN Money.

MYGN stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials. Discover the future of Myriad Genetics and how were empowering every individual by revealing the answers inside each of us.

Find the latest analyst research for Myriad Genetics Inc. Find the latest Myriad Genetics Inc. Tracking these expectations and their changes is an important component of stock analysis and tracking significant revisions can be turned into a.

As of the latest analysis there are 4263582 shares shorted. Get Started for Free. On average they expect Myriad Genetics share price to reach 3000 in the next year.

Learn about MYGN XNAS with our data and independent analysis including price star rating valuation dividends and financials. This suggests a possible upside of 148 from the stocks current price. BRACAnalysis a DNA sequencing test to assess the risk of developing breast and ovarian.

In-depth view of key statistics and finances for MYRIAD GENETICS INC. Real time Myriad Genetics MYGN stock price quote stock graph news analysis. Salt Lake City UT 84108.

Stock news by MarketWatch. MYGN Complete Myriad Genetics Inc. Streamline your stock and etf research workflows usin objective and actionable research.

Technical analysis of myriad genetics inc. View real-time stock prices and stock quotes for a full financial overview. Myriad Genetics Inc MYD.

See Myriad Genetics Inc. Is currently approximately 2661 per share. All Straight from Industry Pros.

Illuminating the path to better health through genetic insights. Exclusive research and insights from bulls and bears. Ad Save time and get better profits with solid stock ETF research.

Myriad Genetics Inc a molecular diagnostic company develops and markets predictive personalized and prognostic medicine tests in the United States and internationally. Summary of all time highs changes and price drops for Myriad Genetics. Myriad Genetics Naive Prediction.

Over the last year myriad genetics incs stock price has increased by 4613.

Here S Why You Should Retain Myriad Genetics Mygn For Now